News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Almirall Prodesfarma Key Drug Trials Disappoint Investors



9/3/2008 6:38:02 AM

MADRID, Sept 3 (Reuters) - Spanish drug firm Almirall said the results of advanced trials for its key lung disease drug showed it was less effective than in previous trials, sending shares plummeting 18 percent.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES